JPRN-UMIN000053550
Completed
未知
A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer. - A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer.
iigata University Medical and Dental Hospital0 sites165 target enrollmentFebruary 6, 2024
ConditionsAdvanced or recurrent lung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Advanced or recurrent lung cancer
- Sponsor
- iigata University Medical and Dental Hospital
- Enrollment
- 165
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) FDG uptake on lung region was difficult to evaluate owing to massive consolidation or pleural effusion (2\) Patients with bilateral multiple primary lung cancers.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of 18F-FDG-PET/CT in the diagnosis and treatment response of bone metastasis.bone metastasisJPRN-UMIN000005866ational Cancer Center Research Projects Management expenses Grants from the Government to National Cancer Research Center220
Active, not recruiting
Phase 1
Study to see if new research scans can show how treatment affects the blood supply to kidney cancersPrimary and metastatic cancer. The active substance is a diagnostic agent that identifies angiogenesis associated with tumour growth.MedDRA version: 14.1 Level: PT Classification code 10050018 Term: Renal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10038389 Term: Renal cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-002833-20-GBOxford University Hospitals NHS Trust10
Completed
Not Applicable
Early response evaluation with 18F-FDG PET/CT and immunological profiling of circulating immune cells and tumor-draining lymph nodes in non-small cell lung cancer patients treated with immunotherapy.NL-OMON48669Antoni van Leeuwenhoek Ziekenhuis50
Completed
Not Applicable
Integrated 18F-FDG PET/CT in the staging of patients with suspected primary ovarian cancer.NL-OMON29961Academisch Ziekenhuis Maastricht20
Completed
Not Applicable
[F-18]FDG and [C-11]Acetate PET/CT study for refractory diseasesJPRN-UMIN000023101Tokyo Medical and Dental University40